| |
| |
|
| Insider
Information: |
Matthews Judith M. |
| Relationship: |
Chief Financial Officer |
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
8,135 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,365 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,135 |
|
|
| Total
Value |
$12,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -141.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iterum Therapeutics Plc |
ITRM |
Chief Financial Officer |
2023-03-11 |
8,135 |
2018-05-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2023-03-11 |
4 |
D |
$0.96 |
$2,768 |
D/D |
(2,883) |
8,135 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2023-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,666 |
11,018 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2022-03-14 |
4 |
S |
$0.38 |
$17,910 |
D/D |
(47,132) |
81,500 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2022-03-14 |
4/A |
S |
$0.31 |
$19,635 |
D/D |
(63,340) |
65,292 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2022-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
128,632 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2021-01-26 |
4 |
S |
$1.73 |
$58,592 |
D/D |
(33,868) |
28,632 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2021-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
62,500 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2020-09-30 |
4 |
AS |
$1.64 |
$92,053 |
D/D |
(56,130) |
0 |
0 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2018-05-30 |
4 |
B |
$13.00 |
$52,000 |
D/D |
4,000 |
56,130 |
2.74 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Chief Financial Officer |
• – – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
16,484 |
52,130 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
